These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 33936227)
1. The Diagnostic and Prognostic Roles of Combined Expression of Novel Biomarkers in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma: An Immunohistochemical Study. Alabiad MA; Harb OA; Abozaid M; Embaby A; Mandour D; Hemeda R; Shalaby AM Iran J Pathol; 2021; 16(2):162-173. PubMed ID: 33936227 [TBL] [Abstract][Full Text] [Related]
2. Cancer Stemness-Based Prognostic Immune-Related Gene Signatures in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma. Li N; Li Y; Zheng P; Zhan X Front Endocrinol (Lausanne); 2021; 12():755805. PubMed ID: 34745015 [TBL] [Abstract][Full Text] [Related]
3. Comprehensive Profiling of Genomic and Transcriptomic Differences between Risk Groups of Lung Adenocarcinoma and Lung Squamous Cell Carcinoma. Zengin T; Önal-Süzek T J Pers Med; 2021 Feb; 11(2):. PubMed ID: 33672117 [TBL] [Abstract][Full Text] [Related]
4. LINC00628 is differentially expressed between lung adenocarcinoma and squamous cell carcinoma and is associated with the prognosis of NSCLC. Liu T; Xu S; Liu X Oncol Lett; 2022 Feb; 23(2):55. PubMed ID: 34992687 [TBL] [Abstract][Full Text] [Related]
5. Use of four genes in exosomes as biomarkers for the identification of lung adenocarcinoma and lung squamous cell carcinoma. Cao B; Wang P; Gu L; Liu J Oncol Lett; 2021 Apr; 21(4):249. PubMed ID: 33664813 [TBL] [Abstract][Full Text] [Related]
6. Skp2 expression has different clinicopathological and prognostic implications in lung adenocarcinoma and squamous cell carcinoma. Zhong K; Yang F; Han Q; Chen J; Wang J Oncol Lett; 2018 Sep; 16(3):2873-2880. PubMed ID: 30127874 [TBL] [Abstract][Full Text] [Related]
7. The value of CEP55 gene as a diagnostic biomarker and independent prognostic factor in LUAD and LUSC. Fu L; Wang H; Wei D; Wang B; Zhang C; Zhu T; Ma Z; Li Z; Wu Y; Yu G PLoS One; 2020; 15(5):e0233283. PubMed ID: 32437446 [TBL] [Abstract][Full Text] [Related]
8. Exploring and comparing of the gene expression and methylation differences between lung adenocarcinoma and squamous cell carcinoma. Yang Y; Wang M; Liu B J Cell Physiol; 2019 Apr; 234(4):4454-4459. PubMed ID: 30317601 [TBL] [Abstract][Full Text] [Related]
9. NSCLC Subtyping in Conventional Cytology: Results of the International Association for the Study of Lung Cancer Cytology Working Group Survey to Determine Specific Cytomorphologic Criteria for Adenocarcinoma and Squamous Cell Carcinoma. Jain D; Nambirajan A; Chen G; Geisinger K; Hiroshima K; Layfield L; Minami Y; Moreira AL; Motoi N; Papotti M; Rekhtman N; Russell PA; Prince SS; Schmitt F; Yatabe Y; Eppenberger-Castori S; Bubendorf L; J Thorac Oncol; 2022 Jun; 17(6):793-805. PubMed ID: 35331963 [TBL] [Abstract][Full Text] [Related]
10. GPC3 affects the prognosis of lung adenocarcinoma and lung squamous cell carcinoma. Ning J; Jiang S; Li X; Wang Y; Deng X; Zhang Z; He L; Wang D; Jiang Y BMC Pulm Med; 2021 Jun; 21(1):199. PubMed ID: 34112123 [TBL] [Abstract][Full Text] [Related]
11. High ECT2 expression is an independent prognostic factor for poor overall survival and recurrence-free survival in non-small cell lung adenocarcinoma. Zhou S; Wang P; Su X; Chen J; Chen H; Yang H; Fang A; Xie L; Yao Y; Yang J PLoS One; 2017; 12(10):e0187356. PubMed ID: 29088286 [TBL] [Abstract][Full Text] [Related]
12. Increased GOLM1 Expression Independently Predicts Unfavorable Overall Survival and Recurrence-Free Survival in Lung Adenocarcinoma. Liu X; Chen L; Zhang T Cancer Control; 2018; 25(1):1073274818778001. PubMed ID: 29843532 [TBL] [Abstract][Full Text] [Related]
13. Shared network pattern of lung squamous carcinoma and adenocarcinoma illuminates therapeutic targets for non-small cell lung cancer. Li P; Kuang X; Zhang T; Ma L Front Surg; 2022; 9():958479. PubMed ID: 36263088 [TBL] [Abstract][Full Text] [Related]
14. PD-L1 and CD47 co-expression predicts survival and enlightens future dual-targeting immunotherapy in non-small cell lung cancer. Yang Z; Peng Y; Guo W; Xu J; Li L; Tian H; Li R; Liu L; Tan F; Gao S; He J Thorac Cancer; 2021 Jun; 12(11):1743-1751. PubMed ID: 33979899 [TBL] [Abstract][Full Text] [Related]
15. LncRNAs are altered in lung squamous cell carcinoma and lung adenocarcinoma. Liu B; Chen Y; Yang J Oncotarget; 2017 Apr; 8(15):24275-24291. PubMed ID: 27903974 [TBL] [Abstract][Full Text] [Related]
16. Network module function enrichment analysis of lung squamous cell carcinoma and lung adenocarcinoma. Li P; Yuan H; Kuang X; Zhang T; Ma L Medicine (Baltimore); 2022 Nov; 101(47):e31798. PubMed ID: 36451444 [TBL] [Abstract][Full Text] [Related]
17. Expression of Zhang X; Nie X; Long J; Yu J; Zhang P; Liu Y; Wu X; Bai Y; Mao J; Liu X; Yuan Y; Zhao H; Li L Ann Transl Med; 2020 Jul; 8(13):819. PubMed ID: 32793664 [TBL] [Abstract][Full Text] [Related]
18. Identification of Immune-Related Gene Signatures in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma. Li N; Wang J; Zhan X Front Immunol; 2021; 12():752643. PubMed ID: 34887858 [TBL] [Abstract][Full Text] [Related]
19. Prognostic value of IL-6R mRNA in lung adenocarcinoma and squamous cell carcinoma. Xu B; Chen Q; Yue C; Lan L; Jiang J; Shen Y; Lu B Oncol Lett; 2018 Sep; 16(3):2935-2948. PubMed ID: 30127882 [TBL] [Abstract][Full Text] [Related]
20. Identification of NR3C2 as a functional diagnostic and prognostic biomarker and potential therapeutic target in non-small cell lung cancer. Sun YY; Gao HC; Guo P; Sun N; Peng C; Cheng ZH; Gu J; Liu JY; Han F Cancer Innov; 2024 Aug; 3(4):e122. PubMed ID: 38948253 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]